Terms: = Lung cancer AND TCF7L2, ENSG00000148737, 6934, TCF-4 AND Prognosis
5 results:
1. Mutations in genes connected with the tcf7l2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
Rice SJ; Liu X; Hyland V; Liu Z; Belani CP
Lung Cancer; 2020 Mar; 141():97-100. PubMed ID: 31986371
[TBL] [Abstract] [Full Text] [Related]
2. A serine in exon 11 determines the full transcriptional activity of tcf-4 in lung carcinoma cells.
Yang B; Xu Y; Wang X; Liu Y
Biochem Biophys Res Commun; 2019 Jan; 508(3):675-681. PubMed ID: 30527807
[TBL] [Abstract] [Full Text] [Related]
3. Long noncoding RNA AFAP1‑AS1 enhances cell proliferation and invasion in osteosarcoma through regulating miR‑4695‑5p/TCF4‑β‑catenin signaling.
Li R; Liu S; Li Y; Tang Q; Xie Y; Zhai R
Mol Med Rep; 2018 Aug; 18(2):1616-1622. PubMed ID: 29901121
[TBL] [Abstract] [Full Text] [Related]
4. Wnt signaling pathway in non-small cell lung cancer.
Stewart DJ
J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006
[TBL] [Abstract] [Full Text] [Related]
5. Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group.
Mountzios G; Emmanouilidis C; Vardakis N; Kontopodis E; Hatzidaki D; Popis E; Karachaliou N; Kotsakis A; Agelidou M; Georgoulias V
Lung Cancer; 2012 Jul; 77(1):146-50. PubMed ID: 22418242
[TBL] [Abstract] [Full Text] [Related]
